APA (7th ed.) Citation

Hanssen, K. M., Murray, J., Pandher, R., Alfred, S., Gamble, L. D., Brand, J., . . . Haber, M. (2025). Arginine depletion potentiates standard-of-care chemo-immunotherapy in preclinical models of high-risk neuroblastoma. Journal of Experimental & Clinical Cancer Research (17569966), 44(1), 1. https://doi.org/10.1186/s13046-025-03502-8

Chicago Style (17th ed.) Citation

Hanssen, Kimberley M., et al. "Arginine Depletion Potentiates Standard-of-care Chemo-immunotherapy in Preclinical Models of High-risk Neuroblastoma." Journal of Experimental & Clinical Cancer Research (17569966) 44, no. 1 (2025): 1. https://doi.org/10.1186/s13046-025-03502-8.

MLA (9th ed.) Citation

Hanssen, Kimberley M., et al. "Arginine Depletion Potentiates Standard-of-care Chemo-immunotherapy in Preclinical Models of High-risk Neuroblastoma." Journal of Experimental & Clinical Cancer Research (17569966), vol. 44, no. 1, 2025, p. 1, https://doi.org/10.1186/s13046-025-03502-8.